There has been a significant shift in the understanding of heart failure caused by transthyretin cardiac amyloidosis, which was once thought to be a rare condition, and the adoption of nuclear imaging for diagnosis has revealed that ATTR-CA is more common in clinical practice than previously believed.
Read More > https://heartfailure.pocn.com/diagnosis/new-insights-and-treatments-transform-outlook-for-transthyretin-cardiac-amyloidosis/
